|
Influenza
Introduction
General Information
Research Plans & Priorities
Meetings
Introduction
Influenza is caused by a virus. It is notable in its ability to produce
annual epidemics of disease in both developed and developing countries.
Previous vaccination or prior infection does not guarantee protection
since the virus varies from year to year.
DMID supports research leading to more effective approaches to control
influenza virus infections. This includes:
- Basic research on virus structure and function, viral pathogenesis,
and the host response due to infection
- Epidemiologic studies on the natural history and ecology of zoonotic
influenza viruses
- Vaccine development and evaluation
- Improved vaccine delivery
- Drug discovery and evaluation
Top of Page
General Information
- News Releases
- Contract
Awarded to Develop Vaccine Against H9N2 Avian Influenza, August
17, 2004
- NIAID Announces Contracts to Develop Vaccine Against H5N1 Avian Influenza, May 27, 2004
- Human
Cases of Avian Influenza A (H5N1) Infection Hong Kong Special Administrative
Region (SAR), February 26, 2003
- A Small Genetic Change
Makes Flu Virus Deadly, September 6, 2001
- A Parasite, a Virus,
and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers,
May 7, 2001
DMID Press Releases
NIAID Newsroom
Top of Page
- Publications
Top of Page
Research Plans & Priorities
Planning for the 21st Century:
Contains information on influenza, including the impact of the disease and
need for research.
- Opportunities and Resources
Top of Page
- Clinical Trials
All Federally and Privately Supported Clinical Trials: clinicaltrials.gov
Top of Page
- Intramural Labs at NIAID researching influenza and related issues
Meetings
See NIAIDs
Calendar of Events
Top of Page
|
